Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 6, 2001, Pages 752-756

  Siger Zajdel, M ^a   Selmaj, K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Familial multiple sclerosis; Magnetic resonance imaging; Magnetisation transfer ratio

Indexed keywords

ADULT; AGE; ARTICLE; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE DURATION; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE INTENSIFIER; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; WHITE MATTER;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CAUSALITY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0035209190     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.6.752     Document Type: Article

References (50)

1. Pratt RTC, Compston AD, McAlpine D. The familial incidence of disseminated sclerosis and its significance. Brain 1951;74:191-232.
2. Miller R. Genetic aspects of multiple sclerosis. Archives of Neurology and Psychiatry (Chicago) 1953;70: 733-40.
3. Shapira K, Poskanzer DC, Miller H. Familial and conjugal multiple sclerosis. Brain 1963; 86:315-32.
4. Mackay RP, Myrianthopoulos NC. Multiple sclerosis in twins and their relatives. Arch Neurol 1966;15:449-62.
5. Compston A. Genetic factors in the etiology of multiple sclerosis. In: McDonald WI, Silberg DH, eds. Multiple Sclerosis. London: Butterworths, 1986; 56-73.
6. Visscher BR, Detels R, Dudley J, et al. Genetic susceptibility to multiple sclerosis. Neurology 1979;29:1354-60.
7. Haile RW, Hodge SE, Visscher BR, et al. Genetic susceptibility to multiple sclerosis: a linkage analysis with age of oneset corrections. Clin Genet 1980;18:160-7.
8. Sadovnik AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risk for children and siblings of patients. Neurology 1988;38:990-1.
9. Ebers GC, Sadovnik AD, Risch NJ and the Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995;377:150-1.
10. Sadovnik AD, Baird PA, Ward RH. Multiple sclerosis updated risk for relatives. Am J Med Genet 1988;29:533-41.
11. Ebers GC, Bulman DE, Sadovnik AD, et al. A population based study of multiple sclerosis in twins. N Engl J Med 1986;315:1638-42.
12. Mumford CJ, Wood NW, Kellar-Wood H, et al. The British Isles survey of multiple sclerosis in twins. Neurology 1994;44:11-15.
13. Sadovnick AD. Genetics of multiple sclerosis in British Columbia and throughout Canada. Ann Neurol 1994;36: S18-S21.
14. Oksenberg JR, Sebaun E, Hauser SL. Genetics of demyelinating disease. Brain Pathol 1996;6:289-302.
15. Ebers GC, et al. A full genome search in multiple sclerosis. Nature Genetics 1996;13:472-6.
16. Dyment DA, Sadovnick AD, Ebers GC. Genetics of multiple sclerosis. Hum Mol Genet 1997;6:1693-98.
17. Ebers GC, Koopman WJ, Hader W, et al. The natural history of multiple sclerosis: a geographically based study 8: familial multiple sclerosis. Brain 2000;123:641-9.
18. Weinshenker BG, Bulman D, Carriere W, et al. A comparison of sporadic and familial multiple sclerosis. Neurology 1990;40:1354-8
19. McDonald WI. Diagnosis of multiple sclerosis. BMJ 1989; 299:635-7.
20. Allen FV, McKeown SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81-91.
21. Newcombe J, Cuzner ML, Roytta M, et al. White matter proteins in multiple sclerosis. J Neurochem 1980;34:700-708.
22. Newcombe J, Woodroofe MN, Cuzner ML. Distribution of glial fibrillary acidic protein in gliosed human white matter. J Neurochem 1986;47:1713-19.
23. Lundbom N. Determination of magnetization transfer contrast in tissue: an MR imaging study of brain tumors. AJR Am J Roentgenol 1992;159:1279-85.
24. Wolff SD, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989;10:135-14.
25. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-91.
26. Lynch SG, Rose JW, Smoker W, et al. MRI in familial multiple sclerosis. Neurology 1990;40:900-3.
27. Tienari PJ, Salonen O, Wilkstrom J, et al. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings. J Neurol Neurosurg Psychiatry 1992;55:883-6.
28. Fulton JC, Grossman RI, Mannon LJ, et al. Familial multiple sclerosis: volumetric assessment in clinically symptomatic and asymptomatic individuals. Mult Scler 1999;5: 74-77.
29. Poser CM, Paty DW, Schneiberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocol. Ann Neurol 1983;13: 227-31.
30. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI critieria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
31. Filippi M, Rocca MA, Comi G. Magnetization transfer ratio of multiple sclerosis lesions with variable duration of enhancement. J Neurol Sci 1998;159:162-5.
32. Brainin M, Neuhold A, Reisner T, et al. Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by mean of quantitative MRI. J Neurol Neurosurg Psychiatry 1989;52:1355-9.
33. Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-7.
34. Filippi M, Campi A, Dousset V, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-82.
35. Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511-55.
36. Hiehle JF, Lenkinski RE, Grossman RI, et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Resort Med 1994;32:285-93.
37. Filippi M, Rocca MA, Minicucci L, et al. Magnetization transfer imaging of patients with definite MS and negative conventional MR. Neurology 1999;52:845-48.
38. Filippi M, Campi A, Martino G, et al. A magnetization transfer study of white matter in siblings of multiple sclerosis patients. J Neuro Sci 1997;147:151-3.
39. Hammond SR, McLeod JG, Macaskill P, et al. Multiple sclerosis in Australia: socio-economic factors. J Neurol Neurosurg Psychiatry 1996;61:311-13.
40. Multiple Sclerosis Genetic Group. Clinical demographics of multiplex families with multiple sclerosis. Ann Neurol 1998;43:530-534.
41. Fazekas F, Strasser-Fuchs S, Schmidt H, et al. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;69:25-8.
42. Kantara OH, Atkinson E J, Hebrink DD, et al. Association of two variants in IL-1β and IL-1 receptor antagonist genes with multiple sclerosis J Neuroimmunol 2000;106:220-227.
43. Schrijver HM, Crusuis JBA, Uitehaag BMJ, et al. Association of interleukin-1β and interleukn 1-receptor antagonist genes with disease severity in MS. Neurolgy 1999;52: 595-9.
44. Myhr KM, Raknes G, Nyland H, et al. Immunoglobulin GFc-receptor (FcγR) IIA and IIIB polymorphism related to disability in MS. Neurology 1999;52:1771-6.
45. Miller DH. Spectrum of abnormalities in multiple sclerosis. In: Miller DH, Kesselring J, McDonald WI, et al, eds. Magnetic Resonance in Multiple Sclerosis. Cambridge: Cambridge University Press, 1997;31-62.
46. Filippi M, Rocca M, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;512:1689-97.
47. Bakshi R, Miletich RS, Kinkel PR, et al. High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 1998;4:228-34.
48. Tortorella C, Viti B, Bozzali M, et al. A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology 2000;54:186-93.
49. Van Waesberghe JHTM, Kamphorst W, De Groot CJA, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747-54.
50. Cercignani M, Iannucci G, Rocca MA, et al. Pathologic damage in MS assessed by diffusion-weighted and magnetization transfer MRI. Neurology 2000;54:1139-44.